RNUOB
This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.
Renascor Resources Limited
π¦πΊ ASX
π Overview
π Performance
π΅ Cost
π Esg
π€ Advanced
π¨βπ©βπ§βπ¦ Community
π
+ 1586.89%
Annual Growth
4 years average annual growth
π΅
$ 500
Minimum Order
Due to regulatory requirements
π
1
Pearlers Invested
Since January 2020
π Overview
Key information
π Fund Overview
Renascor Resources Limited - Option Expiring 31-Dec-2022
π Performance
Price History
+6566.67%
1M
All Time
Graph
Table
Unsure how much or often to invest?
ποΈ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out βπ΅ Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out ββ±οΈ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out βπ΅ Costs
πΌ
N/A
Management Fee
Included in unit price, not charged by Pearler
πΈ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πΈ Net fee calculatorπ€ Advanced information
Technical Info
π° Price*
$0.20
*Price may be up to 24 hours old
π©βπ©βπ¦ Community Insights
How our community is investing
π Pearlers invested in RNUOB
0
π Total Capital Earnings
$37K
π Average investment frequency
43 weeks
π΅ Average investment amount
$7,717
β° Last time a customer invested in RNUOB
951 days
RNUOB investor breakdown
π΅ Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
πΆ Age of investors
18 - 25
26 - 34
35 - 90
π Legal gender of investors
Female
Male
Pearlers who invest in RNUOB also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
π Performance (5Yr p.a)
3.21%
π Share price
$102.85 AUD
π¦πΊ AUSTRALIA
πΈ FINANCIALS
𧱠MATERIALS
β³οΈ DIVERSIFIED
Renascor Resources Ltd. engages in the exploration and evaluation of mineral property. The company is headquartered in Adelaide, South Australia. The company went IPO on 2010-12-15. The firm's projects include Siviour, Carnding, Marree, and Olary. The Carnding Project contains several near-surface, high-grade gold prospects (up to 16 g/t from previous drilling) in South Australia's Central Gawler Craton. At Carnding, the Company is targeting shallow, high-grade gold occurrences. Within the project area, the Company has identified multiple high priority gold targets based on shallow drilling. The Marree Project is a copper-prospective ground position within South Australia's Adelaide Fold Belt. Its exploration program is focused on identifying and drilling prospects for large tonnage Zambian Copper Belt-style, sedimentary copper deposits. The company holds 100% interest in the remaining Marree Project exploration licenses, EL 6170 and EL 6403.
π Performance (5Yr p.a)
91.11%
π Share price
$0.05 AUD
βοΈ MINING
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
π Performance (5Yr p.a)
17.84%
π Share price
$63.14 AUD
π HIGH PRICE GROWTH
πΊπΈ UNITED STATES
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
π Performance (5Yr p.a)
12.69%
π Share price
$141.26 AUD
π€ TECHNOLOGY
π GLOBAL
β³οΈ DIVERSIFIED
π HIGH PRICE GROWTH
Alligator Energy Ltd. engages in the exploration and evaluation of uranium and other energy minerals. The company is headquartered in Brisbane, Queensland. The company went IPO on 2011-02-02. The firm's projects include Samphire, Big Lake, Alligator Rivers (ARUP), and Piedmont. The Samphire Project is located 20 kilometers (km) south of Whyalla in regional South Australia. Samphire comprises two uranium historical prospects (Blackbush and Plumbush). The firm owns 100% of the Big Lake Uranium Project in the Cooper Basin, South Australia, a project targeting discovery of Australiaβs next in situ recovery (ISR) uranium field. The Alligator Rivers Uranium Province contains multiple uranium targets, which include the Caramal uranium resource bearing 6.5 million pounds of uranium at a high-grade of 3,100 parts per million. The Piedmont Project comprises five licenses in Northern Italy, with the Company in joint venture for four of these, focused on a 30km strike zone with multiple historic Nickel-Copper-Cobalt mines.
π Performance (5Yr p.a)
200.00%
π Share price
$0.03 AUD
β‘οΈ ENERGY
Want more shares? Try these...
ReNerve Ltd is a AU-based company operating in Health Care Equipment & Supplies industry. ReNerve Limited is an Australia-based medical device company developing tissue-based products for peripheral nerve repair and replacement and other related soft tissue surgical procedures. The company is focused on developing products that accelerate tissue regeneration while preventing scarring and negative inflammatory responses. Its products include NervAlign Nerve Cuff, NervAlign Nerve Graft and NervAlign Bionic Nerve. NervAlign Nerve Cuff is a soft, compatible protective wrap used to protect repaired injured nerves. The product is being developed for the surgical repair of transected (cut) and damaged nerves. NervAlign nerve grafts offers surgeons the ability to repair damaged nerves (neurotmesis) without the need to harvest the sural nerve from the patient. The company is developing, NervAlign Bionic Nerve, a combination polymer technology and its nerve graft to produce a replacement nerve that contains shaped ionic polymers which would enable the stimulation of the distal end of a nerve injury.
π Share price
$0.14 AUD
π©Ί HEALTH CARE